Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02902562 · ClinicalTrials.gov registry record · NA
Synovitis and Therapy Response in Inflammatory Arthritis With Contrast Enhanced Ultrasound
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT02902562: Completed NA study, sponsored by University of Southern California.
NCT02902562 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02902562, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study is about using contrast-enhanced ultrasound (CEUS) to assess the degree of synovitis (joint inflammation) in patients with inflammatory arthritis, such as rheumatoid arthritis, and whether it can be used for assessing a treatment response. The investigators hope to learn whether contrast enhanced ultrasounds are better than regular imaging techniques, such as MRI, when used to evaluate the response to disease modifying anti-rheumatic drug (DMARD) therapy in inflammatory arthritis.
Primary Outcome
To assess the inter-reader agreement as well as the agreement between CEUS versus MRI determined treatment response.
Interventions
- PROCEDURE Magnetic Resonance Imaging (MRI)
- PROCEDURE Contrast Enhanced Ultrasound (CEUS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2016-08-31 |
| Est. Completion | 2018-08-22 |
| Phase | NA |
What the finished NCT02902562 record still lists
NCT02902562 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT02902562 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02902562 about?
NCT02902562 is a clinical study titled "Synovitis and Therapy Response in Inflammatory Arthritis With Contrast Enhanced Ultrasound". This study is about using contrast-enhanced ultrasound (CEUS) to assess the degree of synovitis (joint inflammation) in patients with inflammatory arthritis, such as rheumatoid arthritis, and whether it can be used for assessing a treatment response. The investigators hope to learn whether contrast ...
What is the current status of trial NCT02902562?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2016-08-31. Estimated completion is 2018-08-22.
What interventions are being tested in trial NCT02902562?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (PROCEDURE), Contrast Enhanced Ultrasound (CEUS) (PROCEDURE).
Who is sponsoring clinical trial NCT02902562?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02902562's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI